1. Home
  2. SHYF vs URGN Comparison

SHYF vs URGN Comparison

Compare SHYF & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHYF
  • URGN
  • Stock Information
  • Founded
  • SHYF 1975
  • URGN 2004
  • Country
  • SHYF United States
  • URGN United States
  • Employees
  • SHYF N/A
  • URGN N/A
  • Industry
  • SHYF Auto Manufacturing
  • URGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHYF Consumer Discretionary
  • URGN Health Care
  • Exchange
  • SHYF Nasdaq
  • URGN Nasdaq
  • Market Cap
  • SHYF 428.3M
  • URGN 463.2M
  • IPO Year
  • SHYF N/A
  • URGN 2017
  • Fundamental
  • Price
  • SHYF $9.12
  • URGN $10.67
  • Analyst Decision
  • SHYF Strong Buy
  • URGN Strong Buy
  • Analyst Count
  • SHYF 2
  • URGN 7
  • Target Price
  • SHYF $15.50
  • URGN $36.75
  • AVG Volume (30 Days)
  • SHYF 289.5K
  • URGN 662.5K
  • Earning Date
  • SHYF 04-24-2025
  • URGN 05-12-2025
  • Dividend Yield
  • SHYF 2.17%
  • URGN N/A
  • EPS Growth
  • SHYF 744.40
  • URGN N/A
  • EPS
  • SHYF 0.01
  • URGN N/A
  • Revenue
  • SHYF $792,886,000.00
  • URGN $90,398,000.00
  • Revenue This Year
  • SHYF $15.03
  • URGN $36.82
  • Revenue Next Year
  • SHYF $8.68
  • URGN $119.10
  • P/E Ratio
  • SHYF $727.54
  • URGN N/A
  • Revenue Growth
  • SHYF N/A
  • URGN 9.29
  • 52 Week Low
  • SHYF $6.82
  • URGN $8.94
  • 52 Week High
  • SHYF $17.56
  • URGN $20.70
  • Technical
  • Relative Strength Index (RSI)
  • SHYF 56.84
  • URGN 50.74
  • Support Level
  • SHYF $8.66
  • URGN $9.63
  • Resistance Level
  • SHYF $9.30
  • URGN $11.75
  • Average True Range (ATR)
  • SHYF 0.55
  • URGN 0.82
  • MACD
  • SHYF 0.16
  • URGN -0.00
  • Stochastic Oscillator
  • SHYF 89.15
  • URGN 51.17

About SHYF The Shyft Group Inc.

The Shyft Group Inc is engaged in specialty vehicle manufacturing and assembly for commercial vehicles (including last-mile delivery, specialty service, and vocation-specific upfit segments) and recreational vehicle industries. Its products include walk-in vans, truck bodies, cargo vans, and pick-up truck upfits used in e-commerce/parcel delivery, upfit equipment used in the mobile retail and utility trades, as well as luxury Class A diesel motorhome custom chassis and contract manufacturing and assembly services. It also supplies replacement parts and offers repair, maintenance, field service, and refurbishment services for the vehicles that the company manufactures.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

Share on Social Networks: